175 related articles for article (PubMed ID: 36396612)
1. Baseline characterization of the ARMADA (Assessing Reliable Measurement in Alzheimer's Disease) study cohorts.
Karpouzian-Rogers T; Ho E; Novack M; Chinkers M; Bedjeti K; Nowinski C; Giordani B; Gershon R; Weintraub S
Alzheimers Dement; 2023 May; 19(5):1974-1982. PubMed ID: 36396612
[TBL] [Abstract][Full Text] [Related]
2. ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods.
Weintraub S; Karpouzian-Rogers T; Peipert JD; Nowinski C; Slotkin J; Wortman K; Ho E; Rogalski E; Carlsson C; Giordani B; Goldstein F; Lucas J; Manly JJ; Rentz D; Salmon D; Snitz B; Dodge HH; Riley M; Eldes F; Ustsinovich V; Gershon R
Alzheimers Dement; 2022 Aug; 18(8):1449-1460. PubMed ID: 34786833
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the NIH Toolbox Odor Identification Test across normal cognition, amnestic mild cognitive impairment, and dementia due to Alzheimer's disease.
Echevarria-Cooper SL; Ho EH; Gershon RC; Weintraub S; Kahnt T
Alzheimers Dement; 2024 Jan; 20(1):288-300. PubMed ID: 37603693
[TBL] [Abstract][Full Text] [Related]
4. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
[TBL] [Abstract][Full Text] [Related]
5. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
[TBL] [Abstract][Full Text] [Related]
6. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
7. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
[TBL] [Abstract][Full Text] [Related]
8. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
[TBL] [Abstract][Full Text] [Related]
9. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mild behavioural impairment and its association with cognitive and functional impairment in normal cognition, mild cognitive impairment, and mild Alzheimer's dementia.
Park JI;
Psychogeriatrics; 2024 May; 24(3):555-564. PubMed ID: 38403289
[TBL] [Abstract][Full Text] [Related]
11. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
Morris JC
Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
13. Predicting progression from mild cognitive impairment to Alzheimer's disease on an individual subject basis by applying the CARE index across different independent cohorts.
Chen J; Chen G; Shu H; Chen G; Ward BD; Wang Z; Liu D; Antuono PG; Li SJ; Zhang Z;
Aging (Albany NY); 2019 Apr; 11(8):2185-2201. PubMed ID: 31078129
[TBL] [Abstract][Full Text] [Related]
14. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
15. Latent Factor Structure and Measurement Invariance of the NIH Toolbox Cognition Battery in an Alzheimer's Disease Research Sample.
Ma Y; Carlsson CM; Wahoske ML; Blazel HM; Chappell RJ; Johnson SC; Asthana S; Gleason CE
J Int Neuropsychol Soc; 2021 May; 27(5):412-425. PubMed ID: 33012297
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
[TBL] [Abstract][Full Text] [Related]
17. Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging.
Rentz DM; Klinger HM; Samaroo A; Fitzpatrick C; Schneider OR; Amagai S; Peipert JD
Alzheimers Dement (Amst); 2023; 15(3):e12473. PubMed ID: 37693224
[TBL] [Abstract][Full Text] [Related]
18. Application of the NIA-AA Research Framework: Towards a Biological Definition of Alzheimer's Disease Using Cerebrospinal Fluid Biomarkers in the AIBL Study.
Burnham SC; Coloma PM; Li QX; Collins S; Savage G; Laws S; Doecke J; Maruff P; Martins RN; Ames D; Rowe CC; Masters CL; Villemagne VL
J Prev Alzheimers Dis; 2019; 6(4):248-255. PubMed ID: 31686097
[TBL] [Abstract][Full Text] [Related]
19. Psychometric Evaluation of the Neuropsychological Test Battery in Individuals with Normal Cognition, Mild Cognitive Impairment, or Mild to Moderate Alzheimer's Disease: Results from a Longitudinal Study.
Harrison JE; Rentz DM; Brashear HR; Arrighi HM; Ropacki MT; Liu E
J Prev Alzheimers Dis; 2018; 5(4):236-244. PubMed ID: 30298182
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease.
Lim YY; Kong J; Maruff P; Jaeger J; Huang E; Ratti E
J Prev Alzheimers Dis; 2022; 9(1):178-183. PubMed ID: 35098989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
